The global demand for PEGylation Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Kilo Tons in 2021 and forecast to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.
PEGylation (or pegylation) is the process of attaching or amalgamating polyethylene glycol (PEG, also known as macrogol in pharmacy) polymer chains to molecules and macrostructures, such as medication, therapeutic protein, or vesicle, in both covalent and non-covalent ways. PEGylation is commonly accomplished by incubating the target molecule with a reactive PEG derivative. The covalent attachment of PEG to a medication or therapeutic protein can """"hide"""" the agent from the host's immune system (reduce immunogenicity and antigenicity) and enhance its hydrodynamic size (size in solution), which extends its circulation duration by reducing renal clearance. Hydrophobic medicines and proteins can also be PEGylated to make them water-soluble.
Market Dynamics
Increased R&D investments by pharmaceutical and biopharmaceutical companies, expansion in the biologics industry, rising prevalence of lifestyle illness, and increased attention and awareness on improving protein stability and circulation half-life are projected to drive market growth. Furthermore, as the number of people infected with chronic diseases rise, the PEGylation market will be fueled by the increased usage of PEGylated protein to treat various chronic diseases. PEGylated molecules provide many advantages, including a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all contribute to the market's continued expansion. But on the other side, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pegylation. The growth and trends of PEGylation Industry provide a holistic approach to this study.
Market Segmentation
This section of the pegylation market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Linear Pegs
- Branched Pegs
- Multi-Arm Pegs
- Others
By Application
- Pharmaceutical Industry
- Medical Equipment
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the PEGylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global PEGylation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pegylation market include NOF, JenKem Technology, Nektar Therapeutics, Dr. Reddy's Laboratories, Merck, Chemgen Pharma, SINOPEG, SunBio, Laysan Bio, Creative PEGWorks. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.